Bernstein analysts identified Biohaven Pharma (NYSE: BHVN) and Beam Therapeutics Inc. (NASDAQ: BEAM) as their top small- to mid-cap (SMID) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE